Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria

International Journal for Parasitology

Volumn 41, Issue 2, 2011, Pages 155-163

  McQuillan, James A ^a   Mitchell, Andrew J ^a   Ho, Yuen Fern ^a   Combes, Valéry ^a   Ball, Helen J ^a   Golenser, Jacob ^b   Grau, Georges E ^a   Hunt, Nicholas H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anti malarial drug; CD8+ T cells; Cerebral malaria; Mouse model; Plasmodium berghei

Indexed keywords

CXCL9 CHEMOKINE; DIHYDROARTEMISININ; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; QUININE;

CELL ORGANELLE; EXPERIMENTAL STUDY; MALARIA; PARASITE; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MALARIA; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFECTION; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; LYMPHOCYTE ACTIVATION; MICROVASCULATURE; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PARASITE LOAD; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; MALARIA; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI;

MURINAE; MUS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 79151481488     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.08.003     Document Type: Article

References (55)

1. Aldieri E., Atragene D., Bergandi L., Riganti C., Costamagna C., Bosia A., Ghigo D. Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation. FEBS Lett. 2003, 552:141-144.
2. Amani V., Vigario A.M., Belnoue E., Marussig M., Fonseca L., Mazier D., Renia L. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 2000, 30:1646-1655.
3. Armah H.B., Wilson N.O., Sarfo B.Y., Powell M.D., Bond V.C., Anderson W., Adjei A.A., Gyasi R.K., Tettey Y., Wiredu E.K., Tongren J.E., Udhayakumar V., Stiles J.K. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar. J. 2007, 6:147.
4. Batty K.T., Gibbons P.L., Davis T.M., Ilett K.F. Pharmacokinetics of dihydroartemisinin in a murine malaria model. Am. J. Trop. Med. Hyg. 2008, 78:641-642.
5. Baptista F.G., Pamplona A., Pena A.C., Mota M.M., Pied S., Vigario A.M. Accumulation of Plasmodium-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect. Immun. 2010, (Epub July 6th).
6. Belnoue E., Kayibanda M., Vigario A.M., Deschemin J.C., van Rooijen N., Viguier M., Snounou G., Renia L. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 2002, 169:6369-6375.
7. Belnoue E., Potter S.M., Rosa D.S., Mauduit M., Gruner A.C., Kayibanda M., Mitchell A.J., Hunt N.H., Renia L. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 2008, 30:544-553.
8. Berendt A.R., Tumer G.D., Newbold C.I. Cerebral malaria: the sequestration hypothesis. Parasitol. Today 1994, 10:412-414.
9. Brown H., Turner G., Rogerson S., Tembo M., Mwenechanya J., Molyneux M., Taylor T. Cytokine expression in the brain in human cerebral malaria. J. Infect. Dis. 1999, 180:1742-1746.
10. Bygbjerg I.C., Svenson M., Theander T.G., Bendtzen K. Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes. Int. J. Immunopharmacol. 1987, 9:513-519.
11. Campanella G.S., Tager A.M., El Khoury J.K., Thomas S.Y., Abrazinski T.A., Manice L.A., Colvin R.A., Luster A.D. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl Acad. Sci. USA 2008, 105:4814-4819.
12. Clark I.A., Rockett K.A. The cytokine theory of human cerebral malaria. Parasitol. Today 1994, 10:410-412.
13. Dieye A., Ndiaye M., Thiam A., Ndiaye R., Diaw M.L., Angel G., Seignot P., Roussilhon C., Sarthou J.L. Prognostic value of cytokines and HLA markers in patients with cerebral malaria in Senegal. Dakar Med. 1998, 43:174-178.
14. Dondorp A.M., Desakorn V., Pongtavornpinyo W., Sahassananda D., Silamut K., Chotivanich K., Newton P.N., Pitisuttithum P., Smithyman A.M., White N.J., Day N.P. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005, 2:e204.
15. Falk S., Goggel R., Heydasch U., Brasch F., Muller K.M., Wendel A., Uhlig S. Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation. Am. J. Respir. Crit. Care Med. 1999, 160:1734-1742.
16. Farber J.M. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc. Natl Acad. Sci. USA 1990, 87:5238-5242.
17. Gantner F., Uhlig S., Wendel A. Quinine inhibits release of tumor necrosis factor, apoptosis, necrosis and mortality in a murine model of septic liver failure. Eur. J. Pharmacol. 1995, 294:353-355.
18. Goldstone S.D., Hunt N.H. Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim. Biophys. Acta 1997, 1355:353-360.
19. Golenser J., Waknine J.H., Krugliak M., Hunt N.H., Grau G.E. Current perspectives on the mechanism of action of artemisinins. Int. J. Parasitol. 2006, 36:1427-1441.
20. Grau G.E., Piguet P.F., Engers H.D., Louis J.A., Vassalli P., Lambert P.H. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J. Immunol. 1986, 137:2348-2354.
21. Grau G.E., Gretener D., Lambert P.H. Prevention of murine cerebral malaria by low-dose cyclosporin A. Immunology 1987, 61:521-525.
22. Grau G.E., Heremans H., Piguet P.F., Pointaire P., Lambert P.H., Billiau A., Vassalli P. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl Acad. Sci. USA 1989, 86:5572-5574.
23. Grau G.E., de Kossodo S. Cerebral malaria: mediators, mechanical obstruction or more?. Parasitol. Today 1994, 10:408-409.
24. Hansen D.S., Bernard N.J., Nie C.Q., Schofield L. NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J. Immunol. 2007, 178:5779-5788.
25. Hunt N.H., Grau G.E. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003, 24:491-499.
26. Hunt N.H., Golenser J., Chan-Ling T., Parekh S., Rae C., Potter S., Medana I.M., Miu J., Ball H.J. Immunopathogenesis of cerebral malaria. Int. J. Parasitol. 2006, 36:569-582.
27. Idro R., Jenkins N.E., Newton C.R. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005, 4:827-840.
28. Jain V., Armah H.B., Tongren J.E., Ned R.M., Wilson N.O., Crawford S., Joel P.K., Singh M.P., Nagpal A.C., Dash A.P., Udhayakumar V., Singh N., Stiles J.K. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar. J. 2008, 7:83.
29. Kossodo S., Monso C., Juillard P., Velu T., Goldman M., Grau G.E. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 1997, 91:536-540.
30. Kremsner P.G., Neifer S., Rasenack T., Bienzle U. Interference by antimalarial drugs with the in-vitro production of reactive nitrogen intermediates by murine macrophages. J. Antimicrob. Chemother. 1993, 31:385-392.
31. Kwiatkowski D., Molyneux M.E., Stephens S., Curtis N., Klein N., Pointaire P., Smit M., Allan R., Brewster D.R., Grau G.E., et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med. 1993, 86:91-98.
32. Li B., Zhang R., Li J., Zhang L., Ding G., Luo P., He S., Dong Y., Jiang W., Lu Y., Cao H., Zheng J., Zhou H. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation. Int. Immunopharmacol. 2008, 8:379-389.
33. Li W.D., Dong Y.J., Tu Y.Y., Lin Z.B. Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int. Immunopharmacol. 2006, 6:1243-1250.
34. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
35. Luster A.D., Unkeless J.C., Ravetch J.V. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985, 315:672-676.
36. Ma N., Hunt N.H., Madigan M.C., Chan-Ling T. Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am. J. Pathol. 1996, 149:1745-1762.
37. Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., Newton C., Winstanley P., Warn P., Peshu N., et al. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 1995, 332:1399-1404.
38. Maruyama N., Kakuta Y., Yamauchi K., Ohkawara Y., Aizawa T., Ohrui T., Nara M., Oshiro T., Ohno I., Tamura G., et al. Quinine inhibits production of tumor necrosis factor-alpha from human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1994, 10:514-520.
39. Mitchell A.J., Hansen A.M., Hee L., Ball H.J., Potter S.M., Walker J.C., Hunt N.H. Early cytokine production is associated with protection from murine cerebral malaria. Infect. Immun. 2005, 73:5645-5653.
40. Miu J., Mitchell A.J., Muller M., Carter S.L., Manders P.M., McQuillan J.A., Saunders B.M., Ball H.J., Lu B., Campbell I.L., Hunt N.H. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J. Immunol. 2008, 180:1217-1230.
41. Nie C.Q., Bernard N.J., Norman M.U., Amante F.H., Lundie R.J., Crabb B.S., Heath W.R., Engwerda C.R., Hickey M.J., Schofield L., Hansen D.S. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 2009, 5:e1000369.
42. Nitcheu J., Bonduelle O., Combadiere C., Tefit M., Seilhean D., Mazier D., Combadiere B. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 2003, 170:2221-2228.
43. Potter S., Chaudhri G., Hansen A., Hunt N.H. Fas and perforin contribute to the pathogenesis of murine cerebral malaria. Redox Rep. 1999, 4:333-335.
44. Potter S., Chan-Ling T., Ball H.J., Mansour H., Mitchell A., Maluish L., Hunt N.H. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int. J. Parasitol. 2006, 36:485-496.
45. Potter S.M., Chan-Ling T., Rosinova E., Ball H.J., Mitchell A.J., Hunt N.H. A role for Fas-Fas ligand interactions during the late-stage neuropathological processes of experimental cerebral malaria. J. Neuroimmunol. 2006, 173:96-107.
46. Pussard E., Bernier A., Fouquet E., Bouree P. Quinine distribution in mice with Plasmodium berghei malaria. Eur. J. Drug Metab. Pharmacokinet. 2003, 28:11-20.
47. Sanni L.A., Thomas S.R., Tattam B.N., Moore D.E., Chaudhri G., Stocker R., Hunt N.H. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am. J. Pathol. 1998, 152:611-619.
48. South-East Asian Quinine Artesunate Malaria Trial Group Artesunate versus quinine for treatment of severe falciparum malaria: a randomized trial. Lancet 2005, 366:717-725.
49. Thumwood C.M., Hunt N.H., Clark I.A., Cowden W.B. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988, 96:579-589.
50. Udomsangpetch R., Chivapat S., Viriyavejakul P., Riganti M., Wilairatana P., Pongponratin E., Looareesuwan S. Involvement of cytokines in the histopathology of cerebral malaria. Am. J. Trop. Med. Hyg. 1997, 57:501-506.
51. Van den Steen P.E., Deroost K., Van Aelst I., Geurts N., Martens E., Struyf S., Nie C.Q., Hansen D.S., Matthys P., Van Damme J., Opdenakker G. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur. J. Immunol. 2008, 38:1082-1095.
52. Veerasubramanian P., Gosi P., Limsomwong C., Walsh D.S. Artesunate and a major metabolite, dihydroartemisinin, diminish mitogen-induced lymphocyte proliferation and activation. Southeast Asian J. Trop. Med. Public Health 2006, 37:838-847.
53. Wang J., Zhou H., Zheng J., Cheng J., Liu W., Ding G., Wang L., Luo P., Lu Y., Cao H., Yu S., Li B., Zhang L. The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release. Antimicrob. Agents Chemother. 2006, 50:2420-2427.
54. WHO Severe falciparum malaria. World Health Organization, communicable diseases cluster. Trans. R. Soc. Trop. Med. Hyg. 2000, 94(Suppl. 1):S1-S90.
55. WHO World Malaria Report 2008, World Health Organization, Geneva.